✦ LIBER ✦

Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review

✍ Scribed by Patard, J. J. ;Saint, F. ;Velotti, F. ;Abbou, C. C. ;Chopin, D. K.

Publisher: Springer
Year: 1998
Tongue: English
Weight: 138 KB
Volume: 26
Category: Article
ISSN: 0300-5623
DOI: 10.1007/s002400050039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary interleukins in patients receivi

Urinary interleukins in patients receiving intravesical bacillus calmette-guerin therapy for superficial bladder cancer

✍ Jonathan D. Fleischmann; Zahra Toossi; Jerrold J. Ellner; Deborah B. Wentworth; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Intravesical administration of Bacillus Calmette-Guerin (BCG) causes a localized cell-mediated immune response. The intensity of this inflammatory response may be gauged by measuring the levels of both interleukin-2 (IL-2) and an inhibitor of interleukin-2 (IL-2-IN) activity in the urine during

Increased urinary albumin indicating uro

Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer

✍ de Boer, E. C. ;De Reijke, T. M. ;Schamhart, D. H. J. ;Vos, P. C. N. ;Kurth, K. 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 528 KB

Presence of interleukin-2 in urine of su

Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin

✍ W. H. De Jong; E. C. De Boer; A. P. M. Van Der Meijden; P. Vegt; P. A. Steerenbe 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 664 KB

Immunohistochemical evaluation of p53, p

Immunohistochemical evaluation of p53, proliferating cell nuclear antigen (PCNA) and bcl-2 expression during bacillus calmette-guerin (BCG) intravesical instillation therapy for superficial bladder cancers

✍ Okamura, Takehiko ;Akita, Hidetoshi ;Kawai, Noriysau ;Tozawa, Keiichi ;Yamada, Y 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 241 KB

Urinary IL-2 assay for monitoring intrav

Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy

✍ Fabien Saint; Nathalie Kurth; Pascale Maille; Dimitri Vordos; Andre Hoznek; Pasc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 670 KB

## Abstract We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bl

Presence of activated lymphocytes in the

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

✍ E. C. De Boer; W. H. De Jong; A. P. M. Van Der Meijden; P. A. Steerenberg; J. A. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 885 KB